FRANKFORT, Ky. – Attorney General Daniel Cameron today announced a multistate settlement with medical device manufacturer Boston Scientific Corporation (Boston Scientific), resolving allegations of deceptive marketing of transvaginal surgical mesh devices for women. The settlement requires Boston Scientific to pay $188.6 million to 47 states and the District of Columbia. Kentucky will receive $2,934,694 million.
“Deceptive marketing practices prevent Kentuckians from making informed decisions about products and have no place in Kentucky’s marketplace,” Cameron said. “This settlement resolves allegations that Boston Scientific Corporation misled Kentuckians regarding the dangers associated with their surgical mesh devices. It also secures nearly $3 million for the commonwealth and requires the company to revise their marketing, training and clinical trial materials for future consumers.”
Surgical mesh is a synthetic woven fabric that is implanted in the pelvic floor to treat common health conditions in women such as stress urinary incontinence and pelvic organ prolapse. These are common conditions faced by women due to a weakening in their pelvic floor muscles caused by childbirth, age, or other factors.